Paper12373442
Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS and 4 others. Psychopharmacology (Berl), 2002. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys. Papers, record 12373442. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12373442
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzeneacetamides | Major topic |
| Conditioning, Operant | Major topic |
| Naltrexone | Major topic |
| Narcotic Antagonists | Major topic |
| Receptors, Opioid, kappa | Major topic |
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | |
| Analgesics | |
| Analgesics, Non-Narcotic | |
| Animals | |
| Benzamides | |
| Dose-Response Relationship, Drug | |
| Drug Interactions | |
| Female | |
| Guanidines | |
| Macaca mulatta | |
| Male | |
| Morphinans | |
| Morphine | |
| Narcotics | |
| Piperazines | |
| Pyrrolidines | |
| Receptors, Opioid, delta | |
| Reinforcement Schedule | |
| Time Factors |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K05-DA00101 | NIDA NIH HHS | United States | K05DA000101 | PubMed and NIH | NIH RePORTER |
| R01-DA-01533 | NIDA NIH HHS | United States | R01DA001533 | PubMed and NIH | NIH RePORTER |
| R01-DA02519 | NIDA NIH HHS | United States | R01DA002519 | PubMed and NIH | NIH RePORTER |
| R01-DA11460 | NIDA NIH HHS | United States | R01DA011460 | PubMed and NIH | NIH RePORTER |
| U19-DA11007 | NIDA NIH HHS | United States | U19DA011007 | PubMed and NIH | NIH RePORTER |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33997152 | κ-Opioid receptor antagonism reverses heroin withdrawal-induced hyperalgesia in male and female rats. | Neurobiol Stress | 2021 | https://conductscience.org/library/papers/33997152 | PubMed |
| 33454858 | Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands. | Handb Exp Pharmacol | 2022 | https://conductscience.org/library/papers/33454858 | PubMed |
| 32714584 | Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists? | Neuronal Signal | 2018 | https://conductscience.org/library/papers/32714584 | PubMed |
| 31337484 | Chronic Pain Management in the Elderly. | Anesthesiol Clin | 2019 | https://conductscience.org/library/papers/31337484 | PubMed |
| 29273415 | Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl). | Bioorg Med Chem | 2018 | https://conductscience.org/library/papers/29273415 | PubMed |
| 28626834 | Effects of local and spinal administrations of mu-opioids on postoperative pain in aged versus adult mice. | Pain Rep | 2017 | https://conductscience.org/library/papers/28626834 | PubMed |
| 27699938 | Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials. | Depress Anxiety | 2016 | https://conductscience.org/library/papers/27699938 | PubMed |
| 27213169 | Major Depressive Disorder and Kappa Opioid Receptor Antagonists. | Transl Perioper Pain Med | 2016 | https://conductscience.org/library/papers/27213169 | PubMed |
| 26224441 | Analgesic Efficacy of Firocoxib, a Selective Inhibitor of Cyclooxygenase 2, in a Mouse Model of Incisional Pain. | J Am Assoc Lab Anim Sci | 2015 | https://conductscience.org/library/papers/26224441 | PubMed |
| 25485481 | The effects of morphine, naloxone, and κ opioid manipulation on endocrine functioning and social behavior in monogamous titi monkeys (Callicebus cupreus). | Neuroscience | 2015 | https://conductscience.org/library/papers/25485481 | PubMed |
| 23976952 | Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters. | PLoS One | 2013 | https://conductscience.org/library/papers/23976952 | PubMed |
| 23360448 | Development of κ opioid receptor antagonists. | J Med Chem | 2013 | https://conductscience.org/library/papers/23360448 | PubMed |
| 22642416 | Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity. | BMC Pharmacol | 2012 | https://conductscience.org/library/papers/22642416 | PubMed |
| 22261437 | Early role of the κ opioid receptor in ethanol-induced reinforcement. | Physiol Behav | 2012 | https://conductscience.org/library/papers/22261437 | PubMed |
| 21832171 | Duration of action of a broad range of selective κ-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation. | Mol Pharmacol | 2011 | https://conductscience.org/library/papers/21832171 | PubMed |
| 21126550 | Investigation of gastrin-releasing peptide as a mediator for 5'-guanidinonaltrindole-induced compulsive scratching in mice. | Peptides | 2011 | https://conductscience.org/library/papers/21126550 | PubMed |
| 20965223 | Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration. | Prog Neuropsychopharmacol Biol Psychiatry | 2011 | https://conductscience.org/library/papers/20965223 | PubMed |
| 20560148 | Deletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidic conditions, part 2: effects of substitutions on pharmacological activity. | Biopolymers | 2011 | https://conductscience.org/library/papers/20560148 | PubMed |
| 20401607 | Kinase cascades and ligand-directed signaling at the kappa opioid receptor. | Psychopharmacology (Berl) | 2010 | https://conductscience.org/library/papers/20401607 | PubMed |
| 20372878 | Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats. | Psychopharmacology (Berl) | 2010 | https://conductscience.org/library/papers/20372878 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12373442
GET https://conductscience.org/api/papers/v1/12373442/cited_by?page=2